Menu Menu

KPTI    Karyopharm Therapeutics Inc    1503802    
Income Statement
Revenue 38,783,000
Net Income -32,072,000
Profit Margin -82.7%

Balance Sheet
Current Assets 184,755,000
Assets 189,476,000
Current Liabilities 61,493,000
Liabilities 349,123,000
Equity -159,647,000
Shares Out 124,684,000

Cash Flow Statement
Operating Cash Flow -101,676,000
Investing Cash Flow 80,676,000

Market Analysis
Market Cap 96,098,141
Price 0.66
BVPS 43.20
PB 0.02
EPS -0.84
PS 0.62
FCF -21,000,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/29 -0.36
Apr May Jun
5/08 -0.32
Jul Aug Sep
8/06 -0.20
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view KPTI documents filed with the SEC.


KPTI Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: